Hexavalent combination vaccine: programme guidance
Guidance for healthcare professionals on the hexavalent vaccine programme for babies born after 1 August 2017.
- From:
- UK Health Security Agency
- Published
- 5 July 2017
- Last updated
-
1329 May20242025 — See all updates
Applies to England
Documents
Hexavalent DTaP/IPV/Hib/HepB combination vaccine: information for healthcare practitioners
Ref: GOV-16587
HTML
Details
All babies born on or after 1 August 2017 are eligible for the hexavalent vaccine, which includes hepatitis B (HepB), for their primary immunisations.
In 2022, the UK Health Security Agency (UKHSA) will supply Vaxelis® in addition to Infanrix hexa® for use in the primary immunisation schedule.
This document provides information about the 2 hexavalent vaccines for healthcare practitioners who are involved in delivering or advising on the infant primary vaccination programme. AlthoughIt originallyhas publishedbeen asupdated 2to separateinclude documentsthe inchanges 2017to (routinethe programmechildhood guidancevaccination andschedule.
For selectivemore programmeinformation guidance)on thisthe updatedchildhood versionchanges combinesto thesethe 2vaccination documents.schedule
Updates to this page
Published 5 July 2017
Last updated 1329 May 2024
+ show2025
href="#full-history">+ show all updates
-
Sign up for emails or print this page
Update history
2026-08-26 11:43
Updated to reflect that changes to the childhood programme have been in place for a year, DOB based cohorts have been updated for clarity
2025-12-17 11:30
Updated to include new training slides for download and updates to the main guidance document to reflect the introduction of MMRV to the routine schedule for children from 1 January 2026
2025-06-02 14:01
Updates made to the guidance for healthcare practitioners relating to the changes to the childhood schedule from 1 July 2025. Additional appendix A added.
2025-05-29 14:32
Added new slide set which includes all the changes to the childhood vaccination programme.
2024-05-13 09:30
Added updated guidance and training slide set.
2023-05-18 16:33
Updated information on incomplete or uncertain vaccination histories and stability of Vaxelis.
Details
All babies born on or after 1 August 2017 are eligible for the hexavalent vaccine, which includes hepatitis B (HepB), for their primary immunisations.
In 2022, the UK Health Security Agency (UKHSA) will supply Vaxelis® in addition to Infanrix hexa® for use in the primary immunisation schedule.
This document provides information about the 2 hexavalent vaccines for healthcare practitioners who are involved in delivering or advising on the infant primary vaccination programme. AlthoughIt originallyhas publishedbeen asupdated 2to separateinclude documentsthe inchanges 2017to (routinethe programmechildhood guidancevaccination andschedule.
For selectivemore programmeinformation guidance)on thisthe updatedchildhood versionchanges combinesto thesethe 2vaccination documents.schedule
Updates to this page
Sign up for emails or print this page
Update history
2026-08-26 11:43
Updated to reflect that changes to the childhood programme have been in place for a year, DOB based cohorts have been updated for clarity
2025-12-17 11:30
Updated to include new training slides for download and updates to the main guidance document to reflect the introduction of MMRV to the routine schedule for children from 1 January 2026
2025-06-02 14:01
Updates made to the guidance for healthcare practitioners relating to the changes to the childhood schedule from 1 July 2025. Additional appendix A added.
2025-05-29 14:32
Added new slide set which includes all the changes to the childhood vaccination programme.
2024-05-13 09:30
Added updated guidance and training slide set.
2023-05-18 16:33
Updated information on incomplete or uncertain vaccination histories and stability of Vaxelis.